Japan biotech xFOREST Therapeutics is teaming up with a drug discovery solutions provider in a research pact aiming to ...

Beijing-based biotech unicorn METiS TechBio has rolled out what it calls the world's first AI-powered nano-delivery platform, ...

After swiftly developing its COVID-19 vaccine in 2020 and launching it late that year, Moderna soon found itself facing ...

We recently published 10 Stocks Jim Cramer Discussed As He Warned About Big Risk To Big Tech. Moderna, Inc. (NASDAQ:MRNA) is ...

On Sept. 4, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. is scheduled to testify before the Senate Finance Committee, where he is expected to face questions about his vaccine ...

Moderna (MRNA) reached $23.51 at the closing of the latest trading day, reflecting a -7.4% change compared to its last close.

In the United States, health mandates traditionally have been tempered by the need to allow people to make personal choices.

Wall Street futures pointed to a cautious start on Monday as investors weighed the latest inflation data and interest rate ...

Poland is in the middle of a quiet makeover, and most people outside the region probably haven’t even noticed.

The doomsday scenario of AI taking all of our jobs has been averted. Instead of coming for our jobs, it's coming into them, ...

To solve a problem, we have to see it clearly. Whether it's an infection by a novel virus or memory-stealing plaques forming ...